Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Drug Delivery Sector (CIX: MSECTOR513)
941.37   +0.64 (+0.07%)
Streaming Delayed Price  /  Updated: 11:08 AM EDT, May 22, 2013  /  Add to My Watchlist      
View: Sector News
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Open 942.37
Prev. Close 940.73
Today's Range 938.14 - 948.82
52wk Range 761.25 - 1310.80
Components
View All
Value % Change
Elan Corp. PLC ADS  12.07
0.00%
Hospira, Inc.  36.06
+0.39%
Nektar Therapeutics  9.600
-1.34%
PetMed Express, Inc.  13.41
+0.75%
Flamel Technologies  4.700
+1.08%
ACURA PHARMACEUTICALS, Inc.  2.320
+0.87%
Columbia Laboratories, Inc.  0.6286
+1.39%
Delcath Systems, Inc.  0.4223
-3.58%
Aradigm Corporation  0.1300
0.00%
Bio-Path Holdings, Inc.  0.4900
0.00%
Top News
More News
Eye-Catching Stocks - AradigmCorporation(OTCBB:ARDM), Argentex Mining Corporation(OTCMKTS:AGXMF), Liberty Coal Energy Corp. (OTCMKTS:LBTG), PENTHOUSE INTL INC (OTCMKTS:PHSL)
Today 9:44 EDT
from SBWire Direct - Latest Press Releases
Top 4 Stocks In The Drug Delivery Industry With The Lowest PEG Ratio
Today 4:28 EDT
Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of PEG ratio. Alkermes plc (NASDAQ: ALKS ) has a PEG ratio of 0.37. Alkermes had $209.30 million in total cash for the latest... Read More
from Latest Articles from Benzinga.com
Results from Phase III Studies of Naloxegol for Treatment of Opioid-Induced Constipation Presented at Digestive Disease Week 2013
May 21, 2013
from Business Wire News Releases
More News
More News
Profitable Trading Secrets Revealed in F, GE, PFE and ELN
May 21, 2013
from Marketwired News Releases
Grifols, S.A. and Aradigm Corporation Announce Signing of Worldwide Licensing Agreement to Develop and Commercialize Pulmaquin™
May 21, 2013
from Business Wire News Releases
Grifols signs deal to license Aradigm's Pulmaquin
May 21, 2013
MADRID, May 21 (Reuters) - Spanish drugmaker Grifols said on Tuesday it has signed an exclusive contract to license U.S. Aradigm Corporation's Pulmaquin compound and may take a stake in the... Read More
from Reuters: Company News
U.S. court ruling favors Cubist in patent case versus Hospira
May 20, 2013
A federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin by Hospira Inc . Read More
from FOX News
U.S. court ruling favors Cubist in patent case vs Hospira
May 20, 2013
May 20 (Reuters) - A U.S. federal court on Monday ruled in favor of Cubist Pharmaceuticals Inc on the interpretation of patent language in a case involving a generic challenge to its lead drug Cubicin... Read More
from Reuters: Company News

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here